Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 2/2019

10.11.2018 | Original Article

Diabetic retinopathy grade as a predictive marker of severity of cardiovascular disease and mortality: DIVERSE Study Group

verfasst von: Kiran Shah, Sundaram Natarajan, Milind Phadke, Onkar C Swami

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Patients with diabetic retinopathy (DR) are more likely to have subclinical cardiovascular disease. Objective of this study was to assess the prevalence and association of DR grades along with comorbidities in patients with established cardiovascular disease (CVD); association of DR grades beyond ocular morbidity, i.e., long-term outcomes among established CVD; influence of DR grades on prognosis in patients undergoing coronary revascularization. This was a single center, retrospective, data analysis of T2DM patients with established CVD. Goodness of fit was analyzed using Pearson’s chi-square test. DR was observed in 64% (n = 2560) of patients (non-proliferative diabetic retinopathy [NPDR] 37%; proliferative diabetic retinopathy [PDR] 27%). DR and CVD were strongly associated; highest association was observed for congestive heart failure (CHF) (n = 1325), followed by myocardial infarction (MI) (n = 795), unstable angina (UA) (n = 275), and cardiomyopathy (n = 165) (p < 0.00001). Patients with NPDR have greater risk of CHF, MI, UA, and cardiomyopathy vs. PDR [HR 1.32, 1.44, 1.2, and 1.75 respectively]. Five-year all-cause mortality was significantly higher in patients with DR (94.2%; n = 766) vs. that in patients with non-DR (5.78%; n = 47) (p < 0.00001). NPDR patients undergoing CABG (n = 765) had lower 5-year mortality than those underwent PTCA (n = 615) (8.36% vs. 25.85%, p < 0.00001).Three times lower 5-year mortality rate was noted in patients with PDR undergoing CABG vs. that in patients undergoing PTCA (n = 265) (25.3 vs. 72.2%, p < 0.00001). DR was strongly associated with CVD with highest association with CHF, followed by MI, UA, and cardiomyopathy. Cardiovascular events, cerebrovascular events, mortality, and all-cause mortality were higher in patients with DR. Higher risk of mortality was noted in NPDR patients who underwent PTCA than in NPDR patients who underwent CABG.
Literatur
1.
2.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487–95.CrossRefPubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487–95.CrossRefPubMed
3.
Zurück zum Zitat The BARI Investigators. Seven year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am CollCardiol. 2000;35:1122–9.CrossRef The BARI Investigators. Seven year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am CollCardiol. 2000;35:1122–9.CrossRef
4.
Zurück zum Zitat King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS, for Emory Angioplasty versus Surgery Trial (EAST) investigators. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am CollCardiol. 2000;35:1116–21.CrossRef King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS, for Emory Angioplasty versus Surgery Trial (EAST) investigators. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am CollCardiol. 2000;35:1116–21.CrossRef
5.
Zurück zum Zitat Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multi-vessel coronary artery disease after surgical or percutaneous coronary revascularization: results of large regional prospective study. J Am CollCardiol. 2001;37:1008–15.CrossRef Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multi-vessel coronary artery disease after surgical or percutaneous coronary revascularization: results of large regional prospective study. J Am CollCardiol. 2001;37:1008–15.CrossRef
6.
Zurück zum Zitat Bailey CC, Sparrow LM. Co-morbidity in patients with sight-threatening diabetic retinopathy. Eye. 2001;15:719–22.CrossRefPubMed Bailey CC, Sparrow LM. Co-morbidity in patients with sight-threatening diabetic retinopathy. Eye. 2001;15:719–22.CrossRefPubMed
7.
Zurück zum Zitat Sullivan P, Caldwell G, Alexander N, Kohner E. Long-term outcome after photocoagulation for proliferative diabetic retinopathy. Diabet Med. 1990;7:788–94.CrossRefPubMed Sullivan P, Caldwell G, Alexander N, Kohner E. Long-term outcome after photocoagulation for proliferative diabetic retinopathy. Diabet Med. 1990;7:788–94.CrossRefPubMed
8.
Zurück zum Zitat Uchio E, Inamura M, Ohno S, Taguchi H, Saeki K. Survival rate after vitreous surgery in patients with diabetic retinopathy. Opthalmologica. 1993;206:83–8.CrossRef Uchio E, Inamura M, Ohno S, Taguchi H, Saeki K. Survival rate after vitreous surgery in patients with diabetic retinopathy. Opthalmologica. 1993;206:83–8.CrossRef
9.
Zurück zum Zitat Hanis CL, Chu HH, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ, et al. Mortality of Mexican Americans with NIDDM. Diabetes Care. 1993;16:82–9.CrossRefPubMed Hanis CL, Chu HH, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ, et al. Mortality of Mexican Americans with NIDDM. Diabetes Care. 1993;16:82–9.CrossRefPubMed
10.
Zurück zum Zitat Gollamuddi SR, Smidydy WE, Schachat AP, et al. Long-term survival rate after vitreous surgery for complications of diabetic retinopathy. Opthalmology. 1991;98:18–22.CrossRef Gollamuddi SR, Smidydy WE, Schachat AP, et al. Long-term survival rate after vitreous surgery for complications of diabetic retinopathy. Opthalmology. 1991;98:18–22.CrossRef
12.
Zurück zum Zitat FilipoCrea C, BaireyMerz N, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J. 2017;38:473–7. FilipoCrea C, BaireyMerz N, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J. 2017;38:473–7.
13.
Zurück zum Zitat Cheung N, Liew G, Wonga TY. Current approaches to retinopathy as a predictor of cardiovascular risk. Experimental approaches to diabetic retinopathy. Front Diabetes Basel, Karger. 2010;20:203–19.CrossRef Cheung N, Liew G, Wonga TY. Current approaches to retinopathy as a predictor of cardiovascular risk. Experimental approaches to diabetic retinopathy. Front Diabetes Basel, Karger. 2010;20:203–19.CrossRef
14.
Zurück zum Zitat Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58:475–80.CrossRefPubMed Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58:475–80.CrossRefPubMed
15.
Zurück zum Zitat Wong TY, Mcintosh R. Systemic associations of retinal vascular signs: a review of recent population-based studies. Opthalmic Physiol Opt. 2005;25:195–204.CrossRef Wong TY, Mcintosh R. Systemic associations of retinal vascular signs: a review of recent population-based studies. Opthalmic Physiol Opt. 2005;25:195–204.CrossRef
16.
Zurück zum Zitat Wong TY, Mcintosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull. 2005;73-74:57–70.CrossRefPubMed Wong TY, Mcintosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull. 2005;73-74:57–70.CrossRefPubMed
17.
Zurück zum Zitat The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multi-vessel disease. N Engl J Med. 1996;335:217–25.CrossRef The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multi-vessel disease. N Engl J Med. 1996;335:217–25.CrossRef
18.
Zurück zum Zitat The BARI Investigators. The final 10-year follow-up results from the BARI randomization trial. J Am Coll Cardiol. 2007;49:1600–6.CrossRef The BARI Investigators. The final 10-year follow-up results from the BARI randomization trial. J Am Coll Cardiol. 2007;49:1600–6.CrossRef
19.
Zurück zum Zitat Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016;4(7):588–97.CrossRefPubMed Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016;4(7):588–97.CrossRefPubMed
20.
Zurück zum Zitat Shah K, Gandhi A, Natarajan S. Diabetic retinopathy awareness and associations with multiple comorbidities. Insights from DIAMOND Study. Indian J Endocr Metab. 2018;22:30–5. Shah K, Gandhi A, Natarajan S. Diabetic retinopathy awareness and associations with multiple comorbidities. Insights from DIAMOND Study. Indian J Endocr Metab. 2018;22:30–5.
21.
Zurück zum Zitat Cheung N, Wang JJ, Klein R, Couper DJ, Sharret AY, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:1742–6.CrossRefPubMed Cheung N, Wang JJ, Klein R, Couper DJ, Sharret AY, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:1742–6.CrossRefPubMed
22.
Zurück zum Zitat Walraveran I, van den Hurk K, et al. Low grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the HOORN Study. J Diabetes Complications. 2014;28:819–23.CrossRef Walraveran I, van den Hurk K, et al. Low grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the HOORN Study. J Diabetes Complications. 2014;28:819–23.CrossRef
23.
Zurück zum Zitat Bonapace S, Rossi A, Lipari P, Bertolini L, Zenari L, Lanzoni L, et al. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes. J Diabetes Complicat. 2015;29(6):822–8.CrossRef Bonapace S, Rossi A, Lipari P, Bertolini L, Zenari L, Lanzoni L, et al. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes. J Diabetes Complicat. 2015;29(6):822–8.CrossRef
24.
Zurück zum Zitat Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR, et al. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol. 2008;51(16):1573–8.CrossRefPubMed Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR, et al. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol. 2008;51(16):1573–8.CrossRefPubMed
25.
Zurück zum Zitat Ohno T, Takamoto S, Ando J, Morita T, Fujita H, Hirata Y, et al. Diabetic retinopathy and coronary stent implantation of sirolimus-eluting stents. J IntervenCardiol. 2007;20:122–31. Ohno T, Takamoto S, Ando J, Morita T, Fujita H, Hirata Y, et al. Diabetic retinopathy and coronary stent implantation of sirolimus-eluting stents. J IntervenCardiol. 2007;20:122–31.
26.
Zurück zum Zitat Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59(23):2051–7.CrossRefPubMed Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59(23):2051–7.CrossRefPubMed
27.
Zurück zum Zitat Ohno T, Takamoto S, Motomura N. Diabetic retinopathy and coronary artery disease from the cardiac surgeon's perspective. Ann Thorac Surg. 2008;85(2):681–9.CrossRefPubMed Ohno T, Takamoto S, Motomura N. Diabetic retinopathy and coronary artery disease from the cardiac surgeon's perspective. Ann Thorac Surg. 2008;85(2):681–9.CrossRefPubMed
28.
Zurück zum Zitat Ohno T, Ando J, Ono M, et al. The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy. Eur J Cardio-Thoracic Surg. 2006;30:881–6.CrossRef Ohno T, Ando J, Ono M, et al. The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy. Eur J Cardio-Thoracic Surg. 2006;30:881–6.CrossRef
29.
Zurück zum Zitat Ohno T, Kobayashi J, Sasako Y, et al. The impact of diabetic retinopathy on long- term outcomes following coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:428–36.CrossRef Ohno T, Kobayashi J, Sasako Y, et al. The impact of diabetic retinopathy on long- term outcomes following coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:428–36.CrossRef
Metadaten
Titel
Diabetic retinopathy grade as a predictive marker of severity of cardiovascular disease and mortality: DIVERSE Study Group
verfasst von
Kiran Shah
Sundaram Natarajan
Milind Phadke
Onkar C Swami
Publikationsdatum
10.11.2018
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 2/2019
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0699-x

Weitere Artikel der Ausgabe 2/2019

International Journal of Diabetes in Developing Countries 2/2019 Zur Ausgabe